Joshua James Souchek
- Sanguine Diagnostics and Therapeutics (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10891734Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
NIH Funding · FY2026
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $400K in linked award amounts across 1 award record · Award-linked rank #37294.
FY2026 award records by amount
NIH award records listing Joshua James Souchek as a PI. Multi-PI records show the full award amount for context.
- 1R44CA306744-01A1R44Contact PIAnti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer$400Kaward amount
Award organization
Organizations that administered FY2026 awards listing Joshua James Souchek as a PI.
FY2026 award administered by Sanguine Diagnostics and Therapeutics (NE).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardSanguine Diagnostics and Therapeutics
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Joshua James Souchek.